Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargment? A review of the literature.

Giuseppe Brisinda; Serafino Vanella; Giorgio Maria

Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargment? A review of the literature.

Giuseppe Brisinda, Serafino Vanella, Giorgio Maria

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	e10-e11
Journal	EUROPEAN UROLOGY. SUPPLEMENTS
Volume	2009
Publication status	Published - 2009

Keywords

Benign prostatic hyperplasia
Botulinum toxin

Cite this

@article{df51d3340b1f494884def2d9320657d9,

title = "Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargment? A review of the literature.",

keywords = "Benign prostatic hyperplasia, Botulinum toxin, Benign prostatic hyperplasia, Botulinum toxin",

author = "Giuseppe Brisinda and Serafino Vanella and Giorgio Maria",

year = "2009",

language = "English",

volume = "2009",

pages = "e10--e11",

journal = "European Urology, Supplements",

issn = "1569-9056",

publisher = "[S.l.] ; Basel : Karger : Elsevier Science",

}

TY - JOUR

T1 - Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargment? A review of the literature.

AU - Brisinda, Giuseppe

AU - Vanella, Serafino

AU - Maria, Giorgio

PY - 2009

Y1 - 2009

KW - Benign prostatic hyperplasia

KW - Botulinum toxin

KW - Benign prostatic hyperplasia

KW - Botulinum toxin

UR - http://hdl.handle.net/10807/11117

M3 - Article

SN - 1569-9056

VL - 2009

SP - e10-e11

JO - European Urology, Supplements

JF - European Urology, Supplements

ER -

Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargment? A review of the literature.

Keywords

Other files and links

Cite this